Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Eliquis Poised To Wake Up U.S. Oral Anticoagulant Market

Dec 24 2012

• By Emily Hayes

Related Content

Pradaxa’s U.S. Label Updated To Cite Clinical Superiority To Warfarin In Stroke Prevention

Jun 11 2012

Mini Sentinel Alleviates FDA Concern Over Pradaxa Bleeding Issue

Nov 02 2012

Apixaban Shows Mortality Advantage, But Will It Survive FDA Scrutiny?

Sep 05 2011

FDA Plays It Safe With Boehringer Ingelheim's Pradaxa By Approving A Single Dosing Option

Oct 20 2010

Oral Anticoagulants Market Snapshot: Big Bucks, But Payers Are On Guard

Oct 25 2010

Pradaxa Bleeding Deaths Spur FDA Concerns, European Label Changes

Dec 07 2011

Related Companies

Boehringer Ingelheim GmbH

Bristol Myers Squibb Company

Pfizer Inc.

Johnson & Johnson

Bayer AG

Additional Topics

Clinical Trials Advertising, Marketing & Sales Pricing Strategies

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window